ENTITY

Actinium Pharmaceuticals (ATNM US)

3
Analysis
Health Care • United States
Actinium Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops pipeline of antibody radiation conjugates for targeted conditioning and combination therapies. Actinium Pharmaceuticals serves clients in the United States.
more
Exchange Announcement • 10 Oct 2026 05:00

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 08 Aug 2026 05:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 19 Jun 2026 05:00

Current Report (Form 8-K | Period ending 2026-06-18)

Exchange Announcement • 30 May 2026 05:10

Current Report (Form 8-K | Period ending 2026-05-27)

Exchange Announcement • 08 May 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x